Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0476089 (
endometrial cancer
)
11,379
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Endometrial cancer
(EC) is one of the most common gynecologic malignancies. Emerging studies had demonstrated the mutations in genes could serve as diagnostic or prognostic markers for human cancers. In this study, we screened mutated genes in EC and found that the mutations in
KIAA1109
, CACNA1C, BSN, AKAP13, CELSR2,
and
HELZ2
were correlated to the overall survival time in patients with EC. Bioinformatics analysis showed
KIAA1109
was involved in regulating NIK/NF-kappaB signaling,
CACNA1C
was found to regulate cell migration and proliferation,
BSN
was found to regulate Wnt signaling pathway,
CELSR2
was involved in regulating cell-cell adhesion, nuclear import, and protein folding,
HELZ2
was found to regulate multiple immune related biological processes, and
AKAP13
was involved in regulating translation, mRNA nonsense-mediated decay, rRNA processing, translational initiation, and mRNA splicing
via
spliceosome. The findings provided a novel therapeutic strategy in patients with EC.
...
PMID:Mutations in
KIAA1109
,
CACNA1C
,
BSN
,
AKAP13
,
CELSR2
, and
HELZ2
Are Associated With the Prognosis in Endometrial Cancer. 3178 99